中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [134]
金属研究所 [22]
广州能源研究所 [22]
科技战略咨询研究院 [11]
烟台海岸带研究所 [6]
力学研究所 [5]
更多
采集方式
OAI收割 [249]
iSwitch采集 [6]
内容类型
期刊论文 [246]
会议论文 [3]
CNKI期刊论文 [2]
专著 [1]
学位论文 [1]
报纸 [1]
更多
发表日期
2025 [11]
2024 [40]
2023 [20]
2022 [26]
2021 [34]
2020 [22]
更多
学科主题
Plant Scie... [2]
Biochemist... [1]
Biology [1]
Cell Biolo... [1]
Chemistry [1]
Electroche... [1]
更多
筛选
浏览/检索结果:
共255条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 68, 期号: 10, 页码: 9864-9885
作者:
Hou, Hui
;
Zhou, Jingyi
;
Sui, Qibang
;
Zhang, Changfa
;
Su, Zhaoming
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2025/07/25
Bridging chemistry and artificial intelligence by a reaction description language
期刊论文
OAI收割
NATURE MACHINE INTELLIGENCE, 2025, 卷号: 7, 期号: 5, 页码: 16
作者:
Xiong, Jiacheng
;
Zhang, Wei
;
Wang, Yinquan
;
Huang, Jiatao
;
Shi, Yuqi
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2025/07/25
Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads
期刊论文
OAI收割
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2025, 卷号: 147, 期号: 18, 页码: 15469-15481
作者:
Wu, Xinyuan
;
Pan, Jiayi
;
Fan, Rufeng
;
Zhang, Yiwei
;
Wang, Chao
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2025/06/23
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
期刊论文
OAI收割
NATURE CANCER, 2025, 页码: 37
作者:
Wang, Hanling
;
Zhang, Sulin
;
Pan, Qiang
;
Guo, Jiacheng
;
Li, Ni
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2025/05/27
Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy
期刊论文
OAI收割
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 卷号: 16, 期号: 1, 页码: 22
作者:
Wang, Bei
;
Wang, Zixuan
;
Xu, Chuanhai
;
Wang, Yueqin
;
Gao, Honglan
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2025/05/27
Geriatric Nutritional Risk Index (GNRI)
esophageal squamous cell carcinoma (ESCC)
immune checkpoint inhibitors (ICIs)
programmed cell death ligand 1 (PD-L1)
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
期刊论文
OAI收割
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1, 页码: 19
作者:
Yao, Mingyue
;
Yan, Wenzhong
;
Wang, Yafang
;
Zhao, Yu
;
Xu, Xiaowei
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2025/04/01
Acute myeloid leukemia
HDAC inhibitor
FLT3-ITD mutation
DNA damage response
Synergistic effect
Drug resistance
Harnessing the Magic Methyl Effect: Discovery of CLPP-2068 as a Novel
Hs
ClpP Activator for the Treatment of Diffuse Large B-Cell Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 68, 期号: 4, 页码: 4287-4307
作者:
Sun, Mingyang
;
Chen, Beijing
;
Teng, Dan
;
Zhao, Hongshen
;
Liao, Yilie
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2025/04/01
Design, synthesis, and structure-activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 282, 页码: 21
作者:
Sui, Qibang
;
Zhou, Yuanyang
;
Li, Manjia
;
Wang, Dan
;
Cui, Rongrong
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2024/12/25
Synthetic lethal
MSI tumors
WRN inhibitors
Triazolo-pyrimidine derivatives
Prediction of Solvate Based on Graph Attention Network
期刊论文
OAI收割
CRYSTAL GROWTH & DESIGN, 2025, 卷号: 25, 期号: 2, 页码: 297-308
作者:
Sun, Shihui
;
Wang, Jian-Rong
;
Tang, Lei
;
Fan, Zhehuan
;
Li, Xutong
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2025/04/01
Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy
期刊论文
OAI收割
CANCER MEDICINE, 2025, 卷号: 14, 期号: 1, 页码: 13
作者:
Wang, Kun
;
Zhang, Yingying
;
Su, Zhaoming
;
Wang, Bei
;
Zhou, Yuanyang
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2025/04/01
biomarker
CDC42
clinical response
immunotherapy
pan-cancer